Rationale, design and baseline data of a randomized. double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in patients with strokes: the prevention regimen for effectively avoiding second strokes trial (PRoFEES)